FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online March 4, 2004 as doi:10.1096/fj.03-0767fje.
Published as doi: 10.1096/fj.03-0767fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/7/929
03-0767fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOBAYASHI, S.
Right arrow Articles by MARU, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KOBAYASHI, S.
Right arrow Articles by MARU, Y.
(The FASEB Journal. 2004;18:929-931.)
© 2004 FASEB

The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1)1

SATSUKI KOBAYASHI*,{dagger}, ASAKO SAWANO*, YOSHIHISA NOJIMA{dagger}, MASABUMI SHIBUYA* and YOSHIRO MARU*,{ddagger},2

* Division of Genetics, Institute of Medical Science, University of Tokyo, Tokyo;
{dagger} Third Department of Internal Medicine, Gunma University School of Medicine, Gunma; and
{ddagger} Department of Pharmacology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

2Correspondence: Department of Pharmacology, Tokyo Women’s Medical University School of Medicine, Shinjuku-ku, Tokyo, 162-8666, Japan. E-mail: ymaru{at}research.twmu.ac.jp

SPECIFIC AIMS

This study is aimed to uncover the molecular mechanisms that underlie the fate of Flt-1 (VEGFR-1) after VEGF stimulation.

PRINCIPAL FINDINGS

1. The vascular endothelial growth factor (VEGF) -dependent interaction between Flt-1 and c-Cbl was clearly observed in NIH3T3 fibroblasts overexpressing Flt-1 (3T3-FLT-1). When the full-length c-Cbl was transfected to 3T3-FLT-1 cells, the complex formation between CD2AP and Flt-1 was also shown to be dependent on VEGF

2. Both the Flt-1 kinase activity and tyrosine residue 1333 in Flt-1 were shown to be required for binding to c-Cbl but not to PLC-{gamma}

3. A c-Cbl mutant study revealed that the SH2 domain of c-Cbl and the rest of the sequence are required for binding to VEGF-activated Flt-1 and to CD2AP, respectively

4. The second SH3 domain of CD2AP has the ability to bind to c-Cbl, which is bound to activated Flt-1

5. VEGF stimulated endocytic trafficking of Flt-1 and c-Cbl, which was impaired by a VEGF receptor kinase inhibitor SU5416 or by the tyrosine to phenylalanine mutation at 1333 (Y1333F) in Flt-1 (Fig. 1 )



View larger version (47K):
[in this window]
[in a new window]
 
Figure 1. The essential role of autophosphorylation site Y1333 in VEGF-stimulated endocytosis of Flt-1. A) CHO cells were cotransfected with the full-length c-Cbl and GFP-fused wild-type Flt-1 at the carboxyl terminus (Flt-1 WT) and stimulated by VEGF for 15 min. Cells were fixed and stained with anti-c-Cbl antibody (rhodamine). GFP signals (left panel), anti-c-Cbl immunofluorescence (middle), and merged signals (right) were observed with (+) or without (–) stimulation by VEGF. B) The Y1333 mutant of Flt-1 (Flt-1 Y1333F) was used instead of wild-type Flt-1 in the same experiment as shown in panel A. C) A VEGFR tyrosine kinase inhibitor SU5416 at 10 µM was added for 3 h before stimulation by VEGF. Note the poor formation of vesicles in panels B and C.

6. Cotransfection of c-Cbl and CD2AP gave large vesicles that contained both of the molecules, which was not observed when a CD2AP mutant was used

7. Transfection of the full-length CD2AP promoted internalization of VEGF-stimulated Flt-1 from the cell surface as well as degradation in 3T3-FLT-1 cells. CD2AP mutants and Flt-1 Y1333F inhibited those events (Fig. 2 )



View larger version (51K):
[in this window]
[in a new window]
 
Figure 2. Dominant-negative forms of CD2AP inhibit degradation of VEGF-stimulated Flt-1. A) Schematic representation of CD2AP and its mutants. The full-length CD2AP (X-CD2AP), amino-terminal half containing the three SH3 domains (X-3SH3), and carboxyl-terminal half with the proline-rich (PXXP) and coiled-coil region (X-PCC) were tagged with Xpress at the amino terminus. B) 3T3-FLT-1 cells transfected with the wild-type c-Cbl in combination with X-CD2AP (squares), X-SH3 (triangles), X-PCC (crosses), and mock (empty Xpress vector) (diamonds) were incubated at 4°C for 1 h with 2 ng/mL 125I-VEGF, then at 37°C for 2–15 min, washed with mild acidic buffers (pH 4.5), and radioactivity at the cell surface was quantitated. Cells were lysed in 1N NaOH to quantify the internalized radioactivity. The ratio of internalized radioactivity relative to that on the surface was plotted against time. C) 3T3-FLT-1 cells transfected with the wild-type c-Cbl in combination with X-CD2AP, X-SH3, or X-PCC were stimulated with VEGF at 100 ng/mL (min) and lysates were subjected to anti-Flt-1 (upper panel) and anti-actin (middle panel) Western blot. Intensities of the Flt-1 bands were quantified and expressed as % of remaining receptors for each time point (bottom panel). D) NIH3T3 cells expressing Flt-1 Y1333F at a level comparable to that in 3T3-FLT-1 cells of panel C were transfected with the wild-type c-Cbl in combination with X-CD2AP and analyzed as in panel C.

8. VEGF-stimulated Flt-1 was ubiquitinated in 3T3-FLT-1 cells, which was inhibited by c-Cbl mutants

CONCLUSIONS AND SIGNIFICANCE

c-Cbl is prebound to CD2AP in the cytoplasm. VEGF-activated Flt-1 recruits the c-Cbl/CD2AP complex at the plasma membrane. The tyrosine to phenylalanine mutation at 1333 (Y1333F) in Flt-1 impairs its binding to c-Cbl. This ternary complex is involved in the formation of endocytic vesicles where Flt-1, c-Cbl, and CD2AP are colocalized. Abrogation of the formation of this complex results in impaired internalization, ubiquitination, degradation, and endocytic vesicle formation. Our data add one example to the current view that receptor tyrosine kinases are negatively regulated by c-Cbl at least by ubiquitination and degradation with the help of CD2AP/CIN85 family of proteins (Fig. 3 ). Since Flt-1 is one of the most difficult receptors in which to examine functions under physiological circumstances, analysis of the fate of a molecule Flt-1 should help explore the fate of cells where it is expressed.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 3. Schematic diagram. Interaction between Flt-1 and the c-Cbl/CD2AP complex in endocytosis. VEGF-induced autophosphorylation of Flt-1 at Y1333 recruits c-Cbl through the SH2 domain of c-Cbl. This association transmits signals to CD2AP precomplexed to c-Cbl via the second SH3 domain of CD2AP. The ternary complex formation participates in the regulation of endocytosis, degradation, and ubiquitination of Flt-1. However, the mechanism may be more complicated. CD2AP may be recruited with Flt-1 in both c-Cbl-dependent and -independent (via molecule X) manners, which is facilitated by VEGF-stimulated activation of Flt-1. Ub: ubiquitin, P: phosphate.

FOOTNOTES

1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.03-0767fje




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Prahst, M. Heroult, A. A. Lanahan, N. Uziel, O. Kessler, N. Shraga-Heled, M. Simons, G. Neufeld, and H. G. Augustin
Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1
J. Biol. Chem., September 12, 2008; 283(37): 25110 - 25114.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. C. Tsui and B. A. Pierchala
CD2AP and Cbl-3/Cbl-c Constitute a Critical Checkpoint in the Regulation of Ret Signal Transduction
J. Neurosci., August 27, 2008; 28(35): 8789 - 8800.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Gaidos, S. Soni, D. J. Oswald, P. A. Toselli, and K. H. Kirsch
Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation
J. Cell Sci., July 15, 2007; 120(14): 2366 - 2377.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
N. C. Gauthier, P. Monzo, T. Gonzalez, A. Doye, A. Oldani, P. Gounon, V. Ricci, M. Cormont, and P. Boquet
Early endosomes associated with dynamic F-actin structures are required for late trafficking of H. pylori VacA toxin
J. Cell Biol., April 23, 2007; 177(2): 343 - 354.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Narazaki and G. Tosato
Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A
Blood, May 15, 2006; 107(10): 3892 - 3901.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
O. Staub and D. Rotin
Role of Ubiquitylation in Cellular Membrane Transport
Physiol Rev, April 1, 2006; 86(2): 669 - 707.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Mukherjee, M. Tessema, and A. Wandinger-Ness
Vesicular Trafficking of Tyrosine Kinase Receptors and Associated Proteins in the Regulation of Signaling and Vascular Function
Circ. Res., March 31, 2006; 98(6): 743 - 756.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Welsch, N. Endlich, G. Gokce, E. Doroshenko, J. C. Simpson, W. Kriz, A. S. Shaw, and K. Endlich
Association of CD2AP with dynamic actin on vesicles in podocytes
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1134 - F1143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Hu and S. R. Hubbard
Structural Characterization of a Novel Cbl Phosphotyrosine Recognition Motif in the APS Family of Adapter Proteins
J. Biol. Chem., May 13, 2005; 280(19): 18943 - 18949.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/7/929
03-0767fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOBAYASHI, S.
Right arrow Articles by MARU, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KOBAYASHI, S.
Right arrow Articles by MARU, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS